image credit- shutterstock
Spain-based IVI RMA Global, the world-leading platform for reproductive medicine, has announced the acquisition of ART Fertility Clinics operations in the United Arab Emirates (UAE) and Saudi Arabia from Gulf Capital, a leading alternative investment firm focused on the Gulf Cooperation Council (GCC) region and the majority shareholder in ART Fertility Clinics.
ART Fertility Clinics is the recognised and feted thought leader in the GCC, which operates across the Emirates. The scope of the transaction includes the three state-of-the-art clinics located in UAE and Saudi Arabia.
This acquisition will expand IVI RMA Global’ s footprint across the GCC, allowing it to provide personalized fertility treatments based upon evidence-based medicine, proprietary research-based protocols that lead to the best medical outcomes whilst ensuring patient safety and satisfaction. Completion of the transaction remains subject to satisfaction of regulatory conditions.
The cornerstone of ART Fertility Clinic’s success and stellar reputation as the provider of the highest level of Fertility Care in the region has been its laser like focus on Research, Science and Innovation, making it a natural fit with IVI RMA Global’ s commitment to clinical excellence and breakthrough medical advancements. ART Fertility Clinics-Middle East invested heavily in science and research with 220 medical publications to date and launched a pioneering genetic testing lab in Abu Dhabi, leading to some of the highest IVF fertility success rates globally.
